High number of candidate gene variants are identified as disease-causing in a period of 4 years

被引:2
|
作者
Hills, Sonia [1 ,2 ]
Li, Qifei [1 ,2 ,3 ,4 ]
Madden, Jill A. [1 ,2 ]
Genetti, Casie A. [1 ,2 ]
Brownstein, Catherine A. [1 ,2 ,5 ]
Schmitz-Abe, Klaus [1 ,2 ,3 ,4 ,5 ,6 ]
Beggs, Alan H. [1 ,2 ,5 ,6 ]
Agrawal, Pankaj B. [1 ,2 ,3 ,4 ,7 ]
机构
[1] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA
[2] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA
[3] Univ Miami, Dept Pediat, Div Neonatol, Miller Sch Med, Miami, FL USA
[4] Jackson Hlth Syst, Miami, FL USA
[5] Harvard Med Sch, Dept Pediat, Boston, MA USA
[6] Broad Inst MIT & Harvard, Cambridge, MA USA
[7] Univ Miami, Div Neonatol, Miller Sch Med, Miami, FL 33136 USA
基金
美国国家卫生研究院;
关键词
candidate gene variants; clinical exome reanalysis; gene-disease association; rare disease; PATHOGENICITY;
D O I
10.1002/ajmg.a.63509
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Advances in bioinformatic tools paired with the ongoing accumulation of genetic knowledge and periodic reanalysis of genomic sequencing data have led to an improvement in genetic diagnostic rates. Candidate gene variants (CGVs) identified during sequencing or on reanalysis but not yet implicated in human disease or associated with a phenotypically distinct condition are often not revisited, leading to missed diagnostic opportunities. Here, we revisited 33 such CGVs from our previously published study and determined that 16 of them are indeed disease-causing (novel or phenotype expansion) since their identification. These results emphasize the need to focus on previously identified CGVs during sequencing or reanalysis and the importance of sharing that information with researchers around the world, including relevant functional analysis to establish disease causality.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Identification of disease-causing variants in children and adolescents with focal segmental glomerulosclerosis
    Draut, S.
    Braunisch, M. C.
    Riedhammer, K. M.
    Herr, P. M.
    Guenthner, R.
    Wagner, M.
    Alhaddad, B.
    Renders, L.
    Heemann, U.
    Schmaderer, C.
    Hoefele, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 216 - 217
  • [32] The interpretation of rare or novel variants: damaging vs. disease-causing
    Gutierrez-Rodrigues, Fernanda
    Calado, Rodrigo T.
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (01) : 3 - 4
  • [33] HDAC Inhibitors Rescue Multiple Disease-Causing CFTR Variants.
    Angles, F. A.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [34] Deregulated Regulators: Disease-Causing cis Variants in Transcription Factor Genes
    van Der Lee, Robin
    Correard, Solenne
    Wasserman, Wyeth W.
    TRENDS IN GENETICS, 2020, 36 (07) : 523 - 539
  • [35] Guidance for estimating penetrance of monogenic disease-causing variants in population cohorts
    Wright, Caroline F.
    Sharp, Luke N.
    Jackson, Leigh
    Murray, Anna
    Ware, James S.
    MacArthur, Daniel G.
    Rehm, Heidi L.
    Patel, Kashyap A.
    Weedon, Michael N.
    NATURE GENETICS, 2024, 56 (09) : 1772 - 1779
  • [36] Detection of disease-causing CFTR variants in state newborn screening programs
    McGarry, Meghan E.
    Ren, Clement L.
    Wu, Runyu
    Farrell, Philip M.
    McColley, Susanna A.
    PEDIATRIC PULMONOLOGY, 2023, 58 (02) : 465 - 474
  • [37] Ubiquitination of disease-causing CFTR variants in a microsome-based assay
    Estabrooks, Samuel K.
    Brodsky, Jeffrey L.
    ANALYTICAL BIOCHEMISTRY, 2020, 604
  • [38] ACTA2 is not a major disease-causing gene for moyamoya disease
    Shimojima, Keiko
    Yamamoto, Toshiyuki
    JOURNAL OF HUMAN GENETICS, 2009, 54 (11) : 687 - 688
  • [39] ACTA2 is not a major disease-causing gene for moyamoya disease
    Keiko Shimojima
    Toshiyuki Yamamoto
    Journal of Human Genetics, 2009, 54 : 687 - 688
  • [40] Heterogeneity of disease-causing variants in the Swedish galactosemia population: Identification of 16 novel GALT variants
    Ohlsson, Annika
    Hunt, Mary
    Wedell, Anna
    von Dobeln, Ulrika
    JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (05) : 1008 - 1018